Login / Signup

Shunt occlusion prior to lenvatinib administration prevents hepatic encephalopathy and hyperammonemia.

Ai KuwaharaRyu SasakiMasanori FukushimaMasafumi HaraguchiSatoshi MiumaHisamitsu MiyaakiKazuhiko Nakao
Published in: JGH open : an open access journal of gastroenterology and hepatology (2020)
Shunt occlusion prior to lenvatinib administration prevented hyperammonemia and hepatic encephalopathy. Shunt occlusion may be an effective treatment option to administer molecular target agents in patients with portosystemic shunts.
Keyphrases
  • pulmonary artery
  • early onset
  • coronary artery
  • pulmonary hypertension
  • mouse model
  • pulmonary arterial hypertension
  • single molecule